Email this article PECULIARITIES OF PSYCHOCORRECTION AND PSYCHOPROPHYLACTICS OF MAIN FORMS IN ANXIETY DISORDERS
- Authors: Yaltonsky V.M1, Atamanov A.A2
-
Affiliations:
- Moscow state medical and stomatologic university
- South-Ural state medical university
- Issue: Vol XLV, No 3 (2013)
- Pages: 33-38
- Section: Articles
- URL: https://journals.eco-vector.com/1027-4898/article/view/13787
- DOI: https://doi.org/10.17816/nb13787
- ID: 13787
Cite item
Full Text
Abstract
There were discussed results of psychocorrective and psychiprophilactic measures with consideration of typism and atypism of clinical manifestations as exemplified of 204 cases of generalized anxiety disorder (GAD) and 189 cases of panic disorder (PD).
Full Text
ОСОБЕННОСТИ ПСИХОКОРРЕКЦИИ И ПСИХОПРОФИЛАКТИКИ ОСНОВНЫХ ФОРМ ТРЕВОЖНЫХ РАССТРОЙСТВ×
About the authors
Vladimir M Yaltonsky
Moscow state medical and stomatologic university
Email: yaltonsky@mail.ru
127473,Моscow,Delegatsky street, 20, building.1
Aleksei A Atamanov
South-Ural state medical university
Email: atamanov_psy@mail.ru
454091, Chelyabinsk,Vorovsky street, 64
References
- Менделевич В.Д. О некоторых психологических механизмах неврозогенеза // Психологический журнал. 1990. №6. С.113‒117
- Менделевич В.Д. Расстройства зависимого поведения (к постановке проблемы) // Российский психиатрический журнал. 2003. №1. С. 5‒9
- Старшенбаум А.В. Суицидология и кризисная психотерапия. М.: Когито-центр, 2005. 376 с
- Цыганков Д.Б., Малыгин В.Л., Агасарян Э.Г., Цыганков Б.Д. Психологические защиты у больных алкоголизмом и паническим расстройством // Журнал неврологии и психиатрии им. С.С. Корсакова. 2008. Т. 108, №11. С. 96–97
- Boden J.M., Fergusson D.M., Horwood L.J. Anxiety disorders and suicidal behaviors in adolescence and young adulthood: findings from a longitudinal study // Psychol. Med. 2007. Vol. 37. P. 431–440
- Davidson J.R., Wittchen H.U., Llorca P.M. et al. Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo controlled trial // Eur. Neuropsychopharmacol. 2008. Vol. 18. P. 673–681
- Grant B.F., Hasin D.S., Stinson F.S. et al. Prevalence, correlates, comorbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the national epidemiologic survey on alcohol and related conditions // Psychol. Med. 2005. Vol. 35. P. 747–759
- Kessler R.C., Berglund P., Demler O. et al. Lifetime prevalence and age of onset distributions of DSM-IV disorders in the national comorbidity survey replication // Arch. Gen. Psychiatry. 2005. Vol. 62. P. 593–602
- Lorenz R.A., Jackson C.W., Saitz M. Adjunctive Use of Atypical Antipsychotics for Treatment-resistant Generalized Anxiety Disorder // Pharmacotherapy. 2010. Vol. 30(9). P. 942‒951
- Menza M.A., Dobkin R.D., Marin H. An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder // J. Clin. Psychopharmacol. 2007. Vol. 27. P. 207–210
- Wittchen H.U. Generalized anxiety disorder: prevalence, burden, and cost to society // Depress Anxiety 2002. Vol. 16. P. 162–171
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).